Adverum Biotechnologies, Inc.
ADVM
$3.08
$0.051.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.26% | -37.41% | -18.99% | 10.10% | 10.67% |
| Total Depreciation and Amortization | -34.73% | -33.87% | -35.28% | -39.31% | -32.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.77% | 6.32% | 13.46% | -11.43% | 43.12% |
| Change in Net Operating Assets | 375.10% | 220.29% | 223.77% | -209.76% | -188.99% |
| Cash from Operations | -48.21% | -22.08% | -1.72% | 2.85% | 7.94% |
| Capital Expenditure | 21.56% | 36.29% | 51.98% | 35.21% | 29.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 403.58% | -77.95% | -142.49% | -142.86% | -113.11% |
| Cash from Investing | 384.68% | -78.58% | -143.24% | -143.65% | -113.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.70% | -99.80% | 24,464.21% | 24,464.83% | 24,515.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 77.91% | 23.53% |
| Cash from Financing | -99.70% | -99.90% | 173,817.39% | 82,610.34% | 47,830.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -649.18% | -223.20% | -337.47% | -162.56% | -20.57% |